News

Viatris (NASDAQ:VTRS) extended gains for the seventh straight session on Monday as it rose 1.48% to close at $8.25. The drugmaker has added over 7% in the past six sessions, with its stock closing ...
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. Follow us ...
PITTSBURGH, April 25, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, will present at the BofA Securities 2025 Healthcare Conference in Las Vegas, NV, on Tuesday ...
Shares of Viatris Inc. VTRS rose 1.48% to $8.25 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 5,528.75 and ...
THE LAWSUIT: A class action securities lawsuit was filed against Viatris Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between August 8, ...
Shares of Viatris Inc. VTRS advanced 1.25% to $8.13 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 and ...
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain of the ...
New York, New York--(Newsfile Corp. - April 27, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 ...
With a market cap of $9.1 billion, Viatris Inc. (VTRS) is a global healthcare company with a portfolio of over a thousand approved molecules, including brands like EpiPen, Lipitor, and Viagra ...
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, will present at the BofA Securities 2025 Healthcare Conference in Las Vegas, NV, on Tuesday, May 13, 2025. The company's presentation will ...
A new study has exposed "serious adverse events" linked to mifepristone, also known as the "abortion pill." Mifepristone is a "pregnancy blocker" that is used in combination with another ...